← Back to Search
Membrane Fluidity Effects Of Estratrienes
Y. Liang, Shana Belford, F. Tang, L. Prokai, J. Hughes
Published 2001 · Biology, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Estrogens have demonstrable neuroprotective effects. This fact has lead to the proposed use of estrogens for the prevention and/or treatment of Alzheimer's disease. The exact protective mechanism estrogens provide is not fully understood. In this report, a potential non-genomic mechanism for estratrienes involving alterations in membrane fluidity was studied. Steroids, such as estrogen, are known to be membrane-active and can alter the lipid packing. In this study we used fluorescent methodologies to address the effect of naturally occurring steroids (17alpha and 17beta-estradiol, testosterone, and progesterone) and new estratriene analogs on membrane fluidity using liposomes and HT-22 hippocampal cells. The study's results indicate steroids, based on the estratriene nucleus, can modulate lipid packing as evidenced by (1) decreased membrane fusion events and (2) decreased membrane fluidity. The effects on the membrane were both time and concentration dependent. It was also demonstrated through rational design estratriene analogs can be synthesized with enhanced membrane effects. Finally, in a glutamate-induced toxicity HT-22 model, we also demonstrated cellular protection with the estratriene-based molecules and analogs. The data suggest the plethora of cellular actions of estrogens may relate to or be influenced by membrane effects of the steroid.
This paper references
Are estrogen receptors cytoplasmic or nuclear? Some immunocytochemical and biochemical studies.
I. Parikh (1987)
Potential role for estrogen replacement in the treatment of Alzheimer's dementia.
L. Schneider (1997)
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease
L. Lue (1999)
Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease.
J. Simpkins (1997)
Physical effects of biologically formed cholesterol oxidation products on lipid membranes investigated with fluorescence depolarization spectroscopy and electron spin resonance.
J. C. Verhagen (1996)
Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects.
V. W. Henderson (1994)
Lipid microdomains in dimyristoylphosphatidylcholine-ceramide liposomes.
J. Holopainen (1997)
The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties.
B. Moosmann (1999)
Hormonal-induced changes on the lipid composition and DPH fluorescence anisotropy of erythrocyte ghost from pre- and postmenopausal women.
C. Marra (1998)
Plasma Membrane Microdomains Act as Concentration Platforms to Facilitate Intoxication by Aerolysin
L. Abrami (1999)
Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat.
J. Simpkins (1997)
Rapid and opposite effects of cortisol and estradiol on human erythrocyte Na+,K+-ATPase activity: relationship to steroid intercalation into the cell membrane.
G. Golden (1999)
Effect of estradiol and tamoxifen on brain membranes: investigation by infrared and fluorescence spectroscopy
A. Dicko (1999)
Progress in the management of Alzheimer's disease.
A. Smith (1998)
Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches
C. Behl (1999)
Control of lipid membrane stability by cholesterol content.
S. Raffy (1999)
Amyloid precursor protein in unique cholesterol-rich microdomains different from caveolae-like domains.
H. Hayashi (2000)
Estradiol binding to synaptosomal plasma membranes of rat brain regions.
A. Horvat (1995)
Estrogen: mechanisms for a rapid action in CA1 hippocampal neurons
R. L. Moss (1999)
The effect of bilayer order and fluidity on detergent‐induced liposome fusion
R. Sáez (1985)
Signaling Within a Caveolae‐Like Membrane Microdomain in Human Neuroblastoma Cells in Response to Fibroblast Growth Factor
A. Davy (2000)
17α-Estradiol Exerts Neuroprotective Effects on SK-N-SH Cells
P. Green (1997)
Estrogen Receptors α and β Form Heterodimers on DNA*
S. Cowley (1997)
A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease
C. Kawas (1997)
Platelet membrane fluidity and plasma malondialdehyde levels in Alzheimer's demented patients with and without family history of dementia
J. Kálmán (1994)
Novel mechanism for non‐genomic action of 17β‐oestradiol on kainate‐induced currents in isolated rat CA1 hippocampal neurones
Q. Gu (1998)
A novel, synergistic interaction between 17 beta-estradiol and glutathione in the protection of neurons against beta-amyloid 25-35-induced toxicity in vitro.
K. Gridley (1998)
Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model
M. Dewar (1985)
17β‐Estradiol attenuates oxidative impairment of synaptic Na+/K+‐ATPase activity, glucose transport, and glutamate transport induced by amyloid β‐peptide and iron
J. Keller (1997)
Long-term and short-term electrophysiological effects of estrogen on the synaptic properties of hippocampal CA1 neurons
M. Wong (1992)
Vitamin E and other antioxidants in neuroprotection.
C. Behl (1999)
Influence of phospholipid unsaturation on the cholesterol distribution in membranes.
M. Pasenkiewicz-Gierula (1991)
A new method for the estimation of partition coefficient
N. Bodor (1989)
Estrogen effects on cognition in menopausal women
B. Sherwin (1997)
Membrane estrogen receptors identified by multiple antibody labeling and impeded‐ligand binding
T. Pappas (1995)
Order in phospholipid Langmuir-Blodgett layers and the effect of the electrical potential of the substrate.
J. Yang (1999)
Influence of chain ordering on the selectivity of dipalmitoylphosphatidylcholine bilayer membranes for permeant size and shape.
T. X. Xiang (1998)
Combined Tacrine and Estrogen Replacement Therapy in Patients with Alzheimer's Disease a, b
L. Schneider (1997)
17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro.
C. Behl (1995)
Principles of fluorescence spectroscopy
J. R. Lakowicz (1983)
Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease.
C. Pike (1999)
Effects of β-amyloid peptides on the fluidity of membranes from frontal and parietal lobes of human brain. High potencies of Aβ1-42 and Aβ1-43
W. Müller (1998)
This paper is referenced by
Effects of Parathyroid Hormone on the Fluidity of the Plasma Membrane Vesicles of Cultured Osteoblasts
J. S. Kang (2001)
Review: The potential for estrogens in preventing Alzheimer's disease and vascular dementia
J. Simpkins (2009)
Mitochondrial mechanisms of estrogen neuroprotection.
J. Simpkins (2010)
Biophysical methods: Complementary tools to study the influence of human steroid hormones on the liposome membrane properties.
Rola Abboud (2018)
Structure-nongenomic neuroprotection relationship of estrogens and estrogen-derived compounds.
L. Prokai (2007)
Cell encapsulation spatially alters crosslink density of poly(ethylene glycol) hydrogels formed from free-radical polymerizations.
S. Chu (2020)
2003 Faculty Bibliography of Publications
M. Lindsey (2000)
Effects of alkylphenols on glycerophospholipids and cholesterol in liver and brain from female Atlantic cod (Gadus morhua).
S. Meier (2007)
Plasmodium falciparum: effect of Solanum nudum steroids on thiol contents and beta-hematin formation in parasitized erythrocytes.
A. Pabón (2009)
Mechanistic investigations on the antioxidant action of a neuroprotective estrogen derivative
K. Prokai-Tatrai (2008)
Novel Mechanisms for Estrogen-Induced Neuroprotection
M. Singh (2006)
Stroke: understanding the differences between males and females
M. Wilson (2013)
Estrogen-Mediated Renoprotection following Cardiac Arrest and Cardiopulmonary Resuscitation Is Robust to GPR30 Gene Deletion
M. Hutchens (2014)
Effect of Progesterone, Its Hydroxylated and Methylated Derivatives, and Dydrogesterone on Lipid Bilayer Membranes
Rola Abboud (2015)
R- and S-Equol have equivalent cytoprotective effects in Friedreich’s Ataxia
T. Richardson (2012)
Chapter 22 – Role of Antioxidant Activity of Estrogens in their Potent Neuroprotection
E. Pérez (2007)
Rapid, non-genomic actions of progesterone and estradiol on steady-state calcium and resting calcium influx in lens epithelial cells
Abbas Samadi (2002)
17β-Estradiol as a Neuroprotective Agent
K. Prokai-Tatrai (2017)
Paradoxical effects of β‐estradiol on epidermal permeability barrier homeostasis
M. Tsutsumi (2007)
The assessment of non-feminizing estrogens for use in neuroprotection
K. Yi (2011)
Gender Differences in Cholesterol Nucleation in Native Bile: Estrogen Is a Potential Contributory Factor
A. C. Brown (2009)
Liposome Fluidity Alters Interactions Between the Ganglioside GM1 and Cholera Toxin B Subunit
J. Terrell (2008)
Development of 17α‐Estradiol as a Neuroprotective Therapeutic Agent: Rationale and Results from a Phase I Clinical Study
J. Dykens (2005)
Brain tissue oxidative damage as a possible mechanism for the deleterious effect of a chronic high dose of estradiol on learning and memory in ovariectomized rats.
Fatimeh Khodabandehloo (2013)
Neuroprotective effects of estratriene analogs: structure‐activity relationships and molecular optimization
E. Pérez (2005)
Chapter 2 17 β-Estradiol as a Neuroprotective Agent Katalin Prokai-Tatrai and Laszlo Prokai
K. Prokai-Tatrai (2018)
Estrogen prevents glutamate-induced apoptosis in C6 glioma cells by a receptor-mediated mechanism
E. A. Sribnick (2006)
Paper VII Effects of alkylphenols on glycerophospholipids and cholesterol in liver and brain from female Atlantic cod (Gadus morhua)
T. C. Andersen (2007)
Photoreceptor preservation in the S334ter model of retinitis pigmentosa by a novel estradiol analog.
J. Dykens (2004)
Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury
E. Engler-Chiurazzi (2017)
Mitochondrial mechanisms of estrogen neuroprotection
J. Simpkins (2008)
Estradiol protects cultured articular chondrocytes from oxygen-radical-induced damage
H. Claassen (2004)See more